Nadia Sherline, MD
Dermatology · Hamden, CTNPI 1568544914
Payments from drug & device makers
Across 826 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Pfizer$2K
- Johnson & Johnson$1K
- Amgen$836
- E.r. Squibb & Sons, L.L.C.$782
- Regeneron Healthcare Solutions, Inc.$741
- plus $7K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 168 | $3,016 |
| Pfizer | 95 | $1,696 |
| Johnson & Johnson | 49 | $1,265 |
| Amgen | 45 | $836 |
| E.r. Squibb & Sons, L.L.C. | 41 | $782 |
| Regeneron Healthcare Solutions, Inc. | 34 | $741 |
| Lilly USA, LLC | 35 | $700 |
| Sun Pharmaceutical Industries Inc. | 36 | $687 |
| Arcutis Biotherapeutics, Inc. | 42 | $671 |
| LEO Pharma Inc. | 38 | $647 |
| Novartis | 32 | $637 |
| Sanofi | 27 | $635 |
| Mayne Pharma Commercial LLC | 34 | $511 |
| Incyte Corporation | 27 | $451 |
| Galderma Laboratories, L.p. | 26 | $413 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 21 | $411 |
| Almirall LLC | 10 | $189 |
| Genentech USA, Inc. | 10 | $163 |
| UCB, Inc. | 8 | $162 |
| Dermavant Sciences, Inc. | 7 | $159 |
| VYNE Pharmaceuticals Inc. | 10 | $149 |
| Journey Medical Corporation | 8 | $137 |
| Boehringer Ingelheim | 5 | $101 |
| Prugen, Inc. Pharmaceuticals | 5 | $96 |
| Organon | 3 | $68 |
| Verrica Pharmaceuticals Inc. | 3 | $67 |
| EPI Health, LLC | 1 | $56 |
| Botanix SB Inc | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $41 |
| LNHC, Inc | 1 | $21 |
| Bristol Myers Squibb | 1 | $19 |
How this compares
$15,572 in reported general payments places this provider in the 80th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Hamden
- Brett KingFairfield$6.1M
- Michael PayetteCromwell$3.4M
- Bruce StroberCromwell$3.3M
- Lisa DonofrioNew Haven$2.3M
- Mona ShahriariCromwell$2.3M
- Jeremy MossMadison$2.2M
- Brittany CraiglowFairfield$1.9M
- Meagen McCuskerEnfield$1.8M
- Christopher BunickNew Haven$1.7M
- Jun LuFarmington$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.